I don't think the sales for the first quarter will be very impressive. They are still doing trials to get full approval of the VA. This will be completed soon and i believe a PR will be coming out detailing this. I also believe there will be a PR coming out soon detailing the JV. If you are still in the game, i certainly wouldn't tap out now. These are just my opinions.
News 
Market Data 
Discover 
